January 7, 2025
RegMed Investors (RMi) Closing Bell: share pricing sustainability wavers
January 6, 2025
RegMed Investors (RMi) Closing Bell: bubblicious?
January 3, 2025
RegMed Investors (RMi) Closing Bell: 2nd session 2025
January 2, 2025
RegMed Investors (RMi) Closing Bell: first session 2025, cell and gene therapy sector bounced as indexes slumped
December 20, 2024
RegMed Investors (RMi) Closing Bell: all cell and gene therapy sector stocks snap to attention
December 20, 2024
RegMed Investors’ (RMi) pre-open: WTF
December 18, 2024
RegMed Investors (RMi) Closing Bell: Jerome speaks with 25 basis point reduction and tanks the markets
December 17, 2024
RegMed Investors (RMi) Closing Bell: from the bottom of the stats, hits and balls keep sector on the board
December 16, 2024
RegMed Investors (RMi) Closing Bell: pop goes the sector
December 13, 2024
RegMed Investors (RMi) Closing Bell: bang, bang; struck in a trading range
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2025 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.